Table 4 Pretreatment characteristics of HCV patients associated with SVR achievement
Pretreatment characteristics of HCV patients | Odd ratio (95% CI) | P-value |
|---|---|---|
Age of patient | 1.07 (0.98–1.16) | 0.10 |
Patient gender | 2.07 (0.24–17.5) | 0.50 |
ITPA rs1127354 | 0.001 (0.00–0.00) | 0.99 |
ITPA rs7270101 | 26.5 (1.8–389) | 0.09 |
Body mass index | 1.10 (0.91–1.33) | 0.31 |
Viral load | 1.00 (1.00–1.00) | 0.92 |
White blood cell count | 0.93 (0.66–1.32) | 0.70 |
Hemoglobin | 0.76 (0.30–1.9) | 0.57 |
Platelet | 0.99 (0.98–1.01) | 0.61 |
Aspartate Aminotransferase | 0.99 (0.96–1.02) | 0.87 |
Alanine aminotransferase | 1.01 (0.98–1.04) | 0.45 |
Bilirubin (Total) | 0.28 (0.010–8.30) | 0.46 |